Routine analysis of drug to antibody ratio and drug distribution with maXis II

Applications | 2020 | BrukerInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Clinical Research
Manufacturer
Bruker
Downloadable PDF for viewing
 

Similar PDF

Complete characterization of a lysine-linked antibody drug conjugate by native LC/MS intact mass analysis and peptide mapping
ATE: Integrated characterization of a lysine-linked antibody-drug conjugate by native intact mass analysis and peptide mapping performed on a hybrid quadrupole-Orbitrap mass spectrometer with high mass range
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications
Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC